Colon Anastomosis

2

Review clinical trials related to Colon Anastomosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Flexagon Plus OTOLoc Colon Anastomosis in Patients Undergoing Surgery

The primary objective of this trial is to investigate the safety and effectiveness of the Flexagon SFM system plus OTOLoc when used to create a Ileo-colic and Colo-colonic anastomoses in participants undergoing colon surgery.

Participants needed: 65
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: GI Windows, Inc.Updated: Feb 13, 2026Locations: 2
Eligibility criteria

Aged 22 years or older at screening [+6]

Known or suspected allergy to silicone, nickel, titanium or Nitinol [+19]

Status: Not yet recruiting

Seal-G/ Seal-G MIST Long-Term Follow-up PMCF (Continue) Study

Postoperative complications following colon anastomosis surgery, such as adhesions, stenosis, stricture and obstruction, can significantly impact patient outcomes. The use of surgical sealants has been proposed as a means to mitigate anastomotic complications by providing a protective barrier over the anastomosis site, reducing the risk or the severity of anastomotic leak. The previous post-market clinical follow-up (PMCF) study assessed the short-term safety and performance of SEAL-G surgical sealants in preventing anastomotic leaks and early post-operative complications. However, long-term data are needed to establish its sustained safety and effectiveness. This continuation study aims to evaluate the long-term impact of the SEAL-G/MIST surgical sealant on post-operative complications over 12+ months after surgery. The study will compare complication rates in patients treated with the surgical sealant to a retrospective comparable control group who underwent similar procedures without the sealant.

Participants needed: 208
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Advanced Medical Solutions Ltd.Updated: Aug 3, 2025
Eligibility criteria

Treatment Group: Patients participated and completed all visits in the previous... [+1]

Patients with missing or incomplete medical records that prevent retrospective c... [+2]